Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Category: early detection
Blood test could reveal transition to cancer in people at risk
Scientists have devised an accurate and sensitive way to test blood to see if a pre-cancerous condition is escalating to outright cancer — potentially enabling treatment early in tumor development...
Early Detection of Cancer Conference set for Oct. 18-20
Leaders in early detection and top scientists and innovators in cancer research and bioengineering will gather in Portland, Oregon, Oct. 18-20, 2022, for the seventh in the series organized by the...
Time to accelerate early detection research
Cancer early detection research is poised to transform patient survival, but significant hurdles stand in the way of translating new findings into clinical application, leaders of the field assert in...
Multi-cancer early detection is on the horizon
Before cancers become deadly, signs of their presence can show up in escaped strands of DNA and other tell-tale molecules. Technical leaps are making it possible to find these signals in blood,...
Highlights from the Fifth Early Detection of Cancer Conference
Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. One of the most important factors in cancer survival is diagnosis at an early stage. Screening...
Early detection: a powerful way to improve cancer survival
Advancing the early detection of lethal cancers is fundamental to treating patients more effectively. But the path forward is not easy to see. It will require multi-disciplinary collaborations,...
Using radiation to boost circulating DNA for ‘liquid biopsies’ of cancer
Testing for tumor DNA in blood is easier and safer than taking a biopsy of tumor tissue. The problem is, early-stage tumors may not shed enough DNA to find in a blood draw. Researchers at OHSU are...
Cancer genome study reveals big window for early detection
Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...
Bringing together the leaders in cancer early detection
The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...
Oregon’s colonoscopy trailblazer steps into new leadership role
Colorectal screening, primarily by colonoscopy, contributed to a steep drop in cancer incidence (Yang et al. 2014). David Lieberman, M.D., professor and head of gastroenterology and hepatology in...